Tudor Investment Corp ET AL Purchases New Stake in Select Medical Holdings Corporation $SEM

Tudor Investment Corp ET AL purchased a new stake in shares of Select Medical Holdings Corporation (NYSE:SEM) in the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 114,204 shares of the health services provider’s stock, valued at approximately $1,466,000.

A number of other hedge funds have also recently modified their holdings of SEM. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of Select Medical by 889.7% during the third quarter. Mitsubishi UFJ Trust & Banking Corp now owns 64,094 shares of the health services provider’s stock worth $823,000 after purchasing an additional 57,618 shares during the period. Dana Investment Advisors Inc. raised its position in Select Medical by 52.9% during the 3rd quarter. Dana Investment Advisors Inc. now owns 524,621 shares of the health services provider’s stock valued at $6,736,000 after purchasing an additional 181,436 shares during the last quarter. Public Sector Pension Investment Board raised its position in Select Medical by 21.3% during the 3rd quarter. Public Sector Pension Investment Board now owns 430,472 shares of the health services provider’s stock valued at $5,527,000 after purchasing an additional 75,530 shares during the last quarter. Western Standard LLC purchased a new stake in Select Medical in the 3rd quarter worth approximately $13,551,000. Finally, CSM Advisors LLC grew its position in shares of Select Medical by 32.0% in the 3rd quarter. CSM Advisors LLC now owns 298,961 shares of the health services provider’s stock worth $3,840,000 after buying an additional 72,546 shares during the last quarter. Hedge funds and other institutional investors own 89.48% of the company’s stock.

Analyst Ratings Changes

SEM has been the subject of a number of recent analyst reports. Benchmark downgraded Select Medical from a “buy” rating to a “hold” rating in a report on Wednesday, March 4th. Weiss Ratings upgraded shares of Select Medical from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday, February 20th. Zacks Research lowered shares of Select Medical from a “hold” rating to a “strong sell” rating in a report on Thursday, February 26th. Wall Street Zen cut shares of Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, March 9th. Finally, Royal Bank Of Canada reaffirmed a “sector perform” rating and set a $16.50 target price (down from $19.00) on shares of Select Medical in a research note on Tuesday, March 3rd. Two equities research analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Select Medical currently has an average rating of “Hold” and a consensus price target of $15.63.

Select Medical Trading Up 0.0%

SEM opened at $16.30 on Monday. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.89. Select Medical Holdings Corporation has a 52 week low of $11.65 and a 52 week high of $18.60. The stock has a market cap of $2.02 billion, a PE ratio of 14.17, a PEG ratio of 0.94 and a beta of 1.22. The business has a 50 day moving average of $15.74 and a 200-day moving average of $14.64.

Select Medical (NYSE:SEM) last posted its quarterly earnings data on Thursday, February 19th. The health services provider reported $0.16 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.07). The firm had revenue of $1.40 billion during the quarter, compared to the consensus estimate of $1.36 billion. Select Medical had a return on equity of 7.26% and a net margin of 2.68%.Select Medical’s revenue for the quarter was up 6.4% compared to the same quarter last year. During the same quarter last year, the company posted $0.18 EPS. Select Medical has set its FY 2026 guidance at 1.220-1.320 EPS. Equities research analysts predict that Select Medical Holdings Corporation will post 1.17 earnings per share for the current fiscal year.

Select Medical announced that its Board of Directors has authorized a share buyback program on Thursday, February 19th that allows the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization allows the health services provider to buy up to 49.5% of its stock through open market purchases. Stock repurchase programs are typically an indication that the company’s board believes its shares are undervalued.

Select Medical Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, March 12th. Investors of record on Monday, March 2nd were given a dividend of $0.0625 per share. This represents a $0.25 dividend on an annualized basis and a yield of 1.5%. The ex-dividend date of this dividend was Monday, March 2nd. Select Medical’s dividend payout ratio (DPR) is 21.74%.

About Select Medical

Select Medical is a leading provider of specialized healthcare services in the United States, operating through two primary business segments: Hospital Division and Outpatient Rehabilitation Division. The Hospital Division offers long-term acute care (LTAC) hospitals and inpatient rehabilitation facilities (IRFs) that serve patients recovering from complex illnesses, trauma or surgery. The Outpatient Rehabilitation Division delivers physical, occupational and speech therapy services through a network of clinic locations and home-based care programs.

Headquartered in Mechanicsburg, Pennsylvania, Select Medical was founded in 1996 and has grown through strategic partnerships, joint ventures and acquisitions.